RSAD2 anticorps (C-Term)
Aperçu rapide pour RSAD2 anticorps (C-Term) (ABIN630161)
Antigène
Voir toutes RSAD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- RSAD2 antibody was raised against the C terminal of RSAD2
-
Purification
- Purified
-
Immunogène
- RSAD2 antibody was raised using the C terminal of RSAD2 corresponding to a region with amino acids YLILDEYMRFLNCRKGRKDPSKSILDVGVEEAIKFSGFDEKMFLKRGGKY
-
-
-
-
Indications d'application
-
WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RSAD2 Blocking Peptide, (ABIN936140), is also available for use as a blocking control in assays to test for specificity of this RSAD2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RSAD2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RSAD2 (Radical S-Adenosyl Methionine Domain Containing 2 (RSAD2))
-
Autre désignation
- RSAD2
-
Sujet
- RSAD2 is a potential antiviral effector.
-
Poids moléculaire
- 40 kDa (MW of target protein)
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Antigène
-